Recent Articles
Who Gets to Heal?
A donor gift with no diagnosis requirement forced a debate inside Thank You Life. Its executive director asks whether documented suffering should remain the price of admission to psychedelic care.
By Meredith Thomas
Filter
Why Perimenopause Belongs in Psychedelic Research
Perimenopause is one of the least-researched transitions in women’s health. Some women are already microdosing…
By Melissa Whippo
Weekly Psychedelic Policy Briefing – August 9, 2026
In this week’s Psychedelic Policy Briefing, Investigative Journalist Jack Gorsline digs into the details of…
By Jack Gorsline
Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?
MAPS co-executive director Ismail Lourido Ali on what the April 2026 executive order, the Texas…
By Ismail L. Ali, JD
The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science
An Emory study is recruiting 800 people who faced post-psychedelic challenges, to learn what recovery…
By Josh Lipson, PhD and Roman Palitsky, MDiv, PhD
Weekly Psychedelic Policy Briefing – August 2, 2026
The House attached psychedelic amendments to the FY2027 defense bill, VA Secretary Doug Collins promoted…
By Jack Gorsline
Psilocybin Trial in Veterans With Treatment-Resistant PTSD Reports 75% Remission at One Month
Nine of twelve veterans with severe, treatment-resistant PTSD no longer met diagnostic criteria a month…